<?xml version="1.0" encoding="UTF-8"?>
<ref id="B28-vaccines-07-00046">
 <label>28.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Wang</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Tai</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Yang</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Zhao</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Sun</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Tseng</surname>
    <given-names>C.K.</given-names>
   </name>
   <name>
    <surname>Jiang</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Zhou</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Du</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Gao</surname>
    <given-names>J.</given-names>
   </name>
  </person-group>
  <article-title>Receptor-binding domain of MERS-CoV with optimal immunogen dosage and immunization interval protects human transgenic mice from MERS-CoV infection</article-title>
  <source>Hum. Vaccin. Immunother.</source>
  <year>2017</year>
  <volume>13</volume>
  <fpage>1615</fpage>
  <lpage>1624</lpage>
  <pub-id pub-id-type="doi">10.1080/21645515.2017.1296994</pub-id>
  <?supplied-pmid 28277821?>
  <pub-id pub-id-type="pmid">28277821</pub-id>
 </element-citation>
</ref>
